{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:13:30Z","timestamp":1779254010133,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["407940_206399"],"award-info":[{"award-number":["407940_206399"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["407940_206399"],"award-info":[{"award-number":["407940_206399"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["407940_206399"],"award-info":[{"award-number":["407940_206399"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Refined, non-invasive analgesic delivery methods are essential for improving animal welfare and ethical standards in laboratory rodent research. Here, we evaluated whether the micropipette-guided drug administration (MDA) method, which promotes voluntary consumption using a sweetened condensed milk vehicle, achieves therapeutically relevant plasma and brain concentrations of two widely used analgesics, carprofen and buprenorphine, in male and female C57BL\/6\u2009N and BALB\/c mice. Carprofen administered via MDA at 5, 15, and 30\u2009mg\/kg produced dose-response relationships and plasma exposure comparable to those observed following conventional subcutaneous (SC) injection of the same doses, with plasma concentrations exceeding the recommended\u00a0therapeutic threshold (\u2009~\u200925\u2009\u03bcg\/mL) in a dose-dependent manner. In contrast, the administration route substantially influenced plasma and brain concentrations of buprenorphine, which was administered at higher doses for MDA (0.5, 1.0, and 2.0\u2009mg\/kg) than for SC injection (0.05, 0.1, and 0.2\u2009mg\/kg) to compensate for presystemic first-pass metabolism. Specifically, SC injections of buprenorphine produced higher plasma concentrations early after administration, whereas MDA caused a dose-dependent delay in peak plasma levels and led to higher plasma concentrations of the major metabolite, buprenorphine-3-glucuronide. Although plasma concentrations of buprenorphine did not reach the recommended therapeutic threshold (1\u2009ng\/mL) for either administration route, brain concentrations exceeded proposed efficacy thresholds (3\u20135\u2009ng\/g) at 8\u2009h post-treatment across all MDA buprenorphine doses. Together, our findings demonstrate that MDA provides an effective alternative to parenteral injection for analgesic treatment, while underscoring the importance of evaluating central drug exposure in addition to plasma concentrations.<\/jats:p>","DOI":"10.1038\/s41386-026-02445-8","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:35:15Z","timestamp":1779248115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Carprofen and buprenorphine delivery using micropipette-guided drug administration (MDA) in mice"],"prefix":"10.1038","author":[{"given":"Olga","family":"Krzyzaniak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frida A. M.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Macsmeila","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"K\u00e4mpfen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulin","family":"Jirkof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7244-0345","authenticated-orcid":false,"given":"Urs","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"2445_CR1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.30802\/AALAS-CM-19-000048","volume":"69","author":"PL Foley","year":"2019","unstructured":"Foley PL, Kendall LV, Turner PV. Clinical Management of Pain in Rodents. Comp Med. 2019;69:468\u201389.","journal-title":"Comp Med"},{"key":"2445_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/00236772241300779","volume":"59","author":"IA Gomez de Segura","year":"2025","unstructured":"Gomez de Segura IA, Seeldrayers S, Flecknell P. Current practices of pain assessment and analgesic use in laboratory mice: A 2022 FELASA Working Group survey. Lab Anim. 2025;59:396\u2013412.","journal-title":"Lab Anim"},{"key":"2445_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/srep14288","volume":"5","author":"SA Stuart","year":"2015","unstructured":"Stuart SA, Robinson ESJ. Reducing the stress of drug administration: implications for the 3Rs. Sci Rep. 2015;5:14288.","journal-title":"Sci Rep"},{"key":"2445_CR4","first-page":"15","volume":"41","author":"JL Sharp","year":"2002","unstructured":"Sharp JL, Zammit TG, Lawson DM. Stress-like responses to common procedures in rats: effect of the estrous cycle. Contemp Top Lab Anim Sci. 2002;41:15\u201322.","journal-title":"Contemp Top Lab Anim Sci"},{"key":"2445_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1258\/002367706778476370","volume":"40","author":"MK Meijer","year":"2006","unstructured":"Meijer MK, Spruijt BM, van Zutphen LFM, Baumans V. Effect of restraint and injection methods on heart rate and body temperature in mice. Lab Anim. 2006;40:382\u201391.","journal-title":"Lab Anim"},{"key":"2445_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/laban.1216","volume":"46","author":"P Jirkof","year":"2017","unstructured":"Jirkof P. Side effects of pain and analgesia in animal experimentation. Lab Anim. 2017;46:123\u20138.","journal-title":"Lab Anim"},{"key":"2445_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/brbi.2000.0619","volume":"16","author":"I-G Rojas","year":"2002","unstructured":"Rojas I-G, Padgett DA, Sheridan JF, Marucha PT. Stress-induced susceptibility to bacterial infection during cutaneous wound healing. Brain Behav Immun. 2002;16:74\u201384.","journal-title":"Brain Behav Immun"},{"key":"2445_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1006\/brbi.1997.0512","volume":"12","author":"DA Padgett","year":"1998","unstructured":"Padgett DA, Marucha PT, Sheridan JF. Restraint stress slows cutaneous wound healing in mice. Brain Behav Immun. 1998;12:64\u201373.","journal-title":"Brain Behav Immun"},{"key":"2445_CR9","doi-asserted-by":"crossref","unstructured":"Flecknell P. Laboratory animal anaesthesia and analgesia. 5th ed. Chantilly: Elsevier Science & Technology; 2023.","DOI":"10.1016\/B978-0-12-818268-0.00006-1"},{"key":"2445_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47186-5","volume":"9","author":"P Jirkof","year":"2019","unstructured":"Jirkof P, Durst M, Klopfleisch R, Palme R, Th\u00f6ne-Reineke C, Buttgereit F, et al. Administration of Tramadol or Buprenorphine via the drinking water for post-operative analgesia in a mouse-osteotomy model. Sci Rep. 2019;9:10749.","journal-title":"Sci Rep"},{"key":"2445_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1258\/002367707780378131","volume":"41","author":"L Jessen","year":"2007","unstructured":"Jessen L, Christensen S, Bjerrum OJ. The antinociceptive efficacy of buprenorphine administered through the drinking water of rats. Lab Anim. 2007;41:185\u201396.","journal-title":"Lab Anim"},{"key":"2445_CR12","first-page":"2306","volume":"10","author":"G Tang","year":"2020","unstructured":"Tang G, Nierath W-F, Palme R, Vollmar B, Zechner D. Analysis of Animal Well-Being When Supplementing Drinking Water with Tramadol or Metamizole during Chronic Pancreatitis. Anim Open Access J MDPI. 2020;10:2306.","journal-title":"Anim Open Access J MDPI"},{"key":"2445_CR13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1258\/la.2012.012018","volume":"46","author":"A Corbett","year":"2012","unstructured":"Corbett A, McGowin A, Sieber S, Flannery T, Sibbitt B. A method for reliable voluntary oral administration of a fixed dosage (mg\/kg) of chronic daily medication to rats. Lab Anim. 2012;46:318\u201324.","journal-title":"Lab Anim"},{"key":"2445_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1258\/la.2009.009029","volume":"44","author":"MC Leach","year":"2010","unstructured":"Leach MC, Forrester AR, Flecknell PA. Influence of preferred foodstuffs on the antinociceptive effects of orally administered buprenorphine in laboratory rats. Lab Anim. 2010;44:54\u201358.","journal-title":"Lab Anim"},{"key":"2445_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1258\/la.2012.012028","volume":"46","author":"KSP Abelson","year":"2012","unstructured":"Abelson KSP, Jacobsen KR, Sundbom R, Kalliokoski O, Hau J. Voluntary ingestion of nut paste for administration of buprenorphine in rats and mice. Lab Anim. 2012;46:349\u201351.","journal-title":"Lab Anim"},{"key":"2445_CR16","first-page":"272","volume":"41","author":"R Goldkuhl","year":"2008","unstructured":"Goldkuhl R, Carlsson H-E, Hau J, Abelson KSP. Effect of subcutaneous injection and oral voluntary ingestion of buprenorphine on post-operative serum corticosterone levels in male rats. Eur Surg Res Eur Chir Forsch Rech Chir Eur. 2008;41:272\u20138.","journal-title":"Eur Surg Res Eur Chir Forsch Rech Chir Eur"},{"key":"2445_CR17","first-page":"74","volume":"55","author":"BF Taylor","year":"2016","unstructured":"Taylor BF, Ramirez HE, Battles AH, Andrutis KA, Neubert JK. Analgesic Activity of Tramadol and Buprenorphine after Voluntary Ingestion by Rats (Rattus norvegicus). J Am Assoc Lab Anim Sci JAALAS. 2016;55:74\u201382.","journal-title":"J Am Assoc Lab Anim Sci JAALAS"},{"key":"2445_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/0023677216668553","volume":"51","author":"S Hestehave","year":"2017","unstructured":"Hestehave S, Munro G, Pedersen TB, Abelson KSP. Antinociceptive effects of voluntarily ingested buprenorphine in the hot-plate test in laboratory rats. Lab Anim. 2017;51:264\u201372.","journal-title":"Lab Anim"},{"key":"2445_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/0023677214551108","volume":"49","author":"A Hovard","year":"2015","unstructured":"Hovard A, Teilmann A, Hau J, Abelson K. The applicability of a gel delivery system for self-administration of buprenorphine to laboratory mice. Lab Anim. 2015;49:40\u201345.","journal-title":"Lab Anim"},{"key":"2445_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.bbi.2020.04.015","volume":"88","author":"J Scarborough","year":"2020","unstructured":"Scarborough J, Mueller F, Arban R, Dorner-Ciossek C, Weber-Stadlbauer U, Rosenbrock H, et al. Preclinical validation of the micropipette-guided drug administration (MDA) method in the maternal immune activation model of neurodevelopmental disorders. Brain Behav Immun. 2020;88:461\u201370.","journal-title":"Brain Behav Immun"},{"key":"2445_CR21","doi-asserted-by":"crossref","unstructured":"Steiner S, Krzyzaniak O, Nilsson FAM, Dietrich M, K\u00e4mpfen L, Johansen P, et al. Sex and strain differences in the micropipette-guided drug administration (MDA) method in mice. Lab Anim. 2025;59:578\u2013587.","DOI":"10.1177\/00236772251320843"},{"key":"2445_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2025.114967","volume":"299","author":"O Krzyzaniak","year":"2025","unstructured":"Krzyzaniak O, Steiner S, Nilsson FAM, Dietrich M, K\u00e4mpfen L, Johansen P, et al. Applicability of the micropipette-guided drug administration (MDA) method for assessing reward-related behaviors in mice. Physiol Behav. 2025;299:114967.","journal-title":"Physiol Behav"},{"key":"2445_CR23","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41386-021-01016-3","volume":"46","author":"J Scarborough","year":"2021","unstructured":"Scarborough J, Mattei D, Dorner-Ciossek C, Sand M, Arban R, Rosenbrock H, et al. Symptomatic and preventive effects of the novel phosphodiesterase-9 inhibitor BI 409306 in an immune-mediated model of neurodevelopmental disorders. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2021;46:1526\u201334.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"2445_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41684-021-00723-0","volume":"50","author":"SM Schalbetter","year":"2021","unstructured":"Schalbetter SM, Mueller FS, Scarborough J, Richetto J, Weber-Stadlbauer U, Meyer U, et al. Oral application of clozapine-N-oxide using the micropipette-guided drug administration (MDA) method in mouse DREADD systems. Lab Anim. 2021;50:69\u201375.","journal-title":"Lab Anim"},{"key":"2445_CR25","doi-asserted-by":"crossref","unstructured":"Pye KR, Lantier L, Ayala JE, Beall C, Ellacott KLJ. Validation of a refined protocol for mouse oral glucose tolerance testing without gavage. BioRxiv Prepr Serv Biol. 2024:2024.09.13.612859.","DOI":"10.1101\/2024.09.13.612859"},{"key":"2445_CR26","doi-asserted-by":"publisher","unstructured":"Cruz Lebr\u00f3n A, Blackwell E, Balbuena Almod\u00f3var P, Syakirah Faiez T, Mummert LA, Sfanos KS Use of Micropipette-Guided Drug Administration as an Alternative Method to Oral Gavage in Rodent Models. J Vis Exp JoVE. 2024. https:\/\/doi.org\/10.3791\/66836.","DOI":"10.3791\/66836"},{"key":"2445_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41684-024-01409-z","volume":"53","author":"D Vanhecke","year":"2024","unstructured":"Vanhecke D, Bugada V, Steiner R, Poli\u0107 B, Buch T. Refined tamoxifen administration in mice by encouraging voluntary consumption of palatable formulations. Lab Anim. 2024;53:205\u201314.","journal-title":"Lab Anim"},{"key":"2445_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bbi.2018.07.014","volume":"73","author":"FS Mueller","year":"2018","unstructured":"Mueller FS, Polesel M, Richetto J, Meyer U, Weber-Stadlbauer U. Mouse models of maternal immune activation: Mind your caging system!. Brain Behav Immun. 2018;73:643\u201360.","journal-title":"Brain Behav Immun"},{"key":"2445_CR29","first-page":"186","volume":"57","author":"VL Oliver","year":"2018","unstructured":"Oliver VL, Thurston SE, Lofgren JL. Using Cageside Measures to Evaluate Analgesic Efficacy in Mice (Mus musculus) after Surgery. J Am Assoc Lab Anim Sci JAALAS. 2018;57:186\u2013201.","journal-title":"J Am Assoc Lab Anim Sci JAALAS"},{"key":"2445_CR30","first-page":"553","volume":"52","author":"JC Ingrao","year":"2013","unstructured":"Ingrao JC, Johnson R, Tor E, Gu Y, Litman M, Turner PV. Aqueous stability and oral pharmacokinetics of meloxicam and carprofen in male C57BL\/6 mice. J Am Assoc Lab Anim Sci JAALAS. 2013;52:553\u20139.","journal-title":"J Am Assoc Lab Anim Sci JAALAS"},{"key":"2445_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/0023677214562849","volume":"49","author":"P Jirkof","year":"2015","unstructured":"Jirkof P, Tourvieille A, Cinelli P, Arras M. Buprenorphine for pain relief in mice: repeated injections vs sustained-release depot formulation. Lab Anim. 2015;49:177\u201387.","journal-title":"Lab Anim"},{"key":"2445_CR32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.2042-7158.1981.tb13848.x","volume":"33","author":"D Brewster","year":"1981","unstructured":"Brewster D, Humphrey MJ, Mcleavy MA. The systemic bioavailability of buprenorphine by various routes of administration. J Pharm Pharmacol. 1981;33:500\u20136.","journal-title":"J Pharm Pharmacol"},{"key":"2445_CR33","first-page":"251","volume":"187","author":"O Kalliokoski","year":"2011","unstructured":"Kalliokoski O, Jacobsen KR, Hau J, Abelson KSP. Serum concentrations of buprenorphine after oral and parenteral administration in male mice. Vet J Lond Engl 1997. 2011;187:251\u20134.","journal-title":"Vet J Lond Engl 1997"},{"key":"2445_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/jphp.12652","volume":"69","author":"A Joshi","year":"2017","unstructured":"Joshi A, Halquist M, Konsoula Z, Liu Y, Jones JP, Heidbreder C, et al. Improving the oral bioavailability of buprenorphine: an in-vivo proof of concept. J Pharm Pharmacol. 2017;69:23\u201331.","journal-title":"J Pharm Pharmacol"},{"key":"2445_CR35","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1177\/0023677213494366","volume":"47","author":"AM Sadler","year":"2013","unstructured":"Sadler AM, Bailey SJ. Validation of a refined technique for taking repeated blood samples from juvenile and adult mice. Lab Anim. 2013;47:316\u20139.","journal-title":"Lab Anim"},{"key":"2445_CR36","unstructured":"Riviere JE, Papich MG, editors. Veterinary pharmacology and therapeutics. Tenth edition. Hoboken, NJ: John Wiley & Sons Inc; 2017."},{"key":"2445_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/neu.2010.1673","volume":"29","author":"O Thau-Zuchman","year":"2012","unstructured":"Thau-Zuchman O, Shohami E, Alexandrovich AG, Trembovler V, Leker RR. The anti-inflammatory drug carprofen improves long-term outcome and induces gliogenesis after traumatic brain injury. J Neurotrauma. 2012;29:375\u201384.","journal-title":"J Neurotrauma"},{"key":"2445_CR38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2885.2004.00617.x","volume":"27","author":"P Lees","year":"2004","unstructured":"Lees P, Landoni MF, Giraudel J, Toutain PL. Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest. J Vet Pharmacol Ther. 2004;27:479\u201390.","journal-title":"J Vet Pharmacol Ther"},{"key":"2445_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.30802\/AALAS-JAALAS-23-000041","volume":"62","author":"BA McKenna","year":"2023","unstructured":"McKenna BA, Weaver HL, Kim J, Bowman MW, Knych HK, Kendall LV. A Pharmacokinetic and Analgesic Efficacy Study of Carprofen in Female CD1 Mice. J Am Assoc Lab Anim Sci JAALAS. 2023;62:545\u201352.","journal-title":"J Am Assoc Lab Anim Sci JAALAS"},{"key":"2445_CR40","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1124\/jpet.104.082560","volume":"313","author":"A Yassen","year":"2005","unstructured":"Yassen A, Olofsen E, Dahan A, Danhof M. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics. J Pharmacol Exp Ther. 2005;313:1136\u201349.","journal-title":"J Pharmacol Exp Ther"},{"key":"2445_CR41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/laban.152","volume":"41","author":"M Guarnieri","year":"2012","unstructured":"Guarnieri M, Brayton C, DeTolla L, Forbes-McBean N, Sarabia-Estrada R, Zadnik P. Safety and efficacy of buprenorphine for analgesia in laboratory mice and rats. Lab Anim. 2012;41:337\u201343.","journal-title":"Lab Anim"},{"key":"2445_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30641-9","volume":"13","author":"A Wolter","year":"2023","unstructured":"Wolter A, Bucher CH, Kurmies S, Schreiner V, Konietschke F, Hohlbaum K, et al. A buprenorphine depot formulation provides effective sustained post-surgical analgesia for 72 h in mouse femoral fracture models. Sci Rep. 2023;13:3824.","journal-title":"Sci Rep"},{"key":"2445_CR43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0022-3565(25)24425-1","volume":"272","author":"M Ohtani","year":"1995","unstructured":"Ohtani M, Kotaki H, Sawada Y, Iga T. Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther. 1995;272:505\u201310.","journal-title":"J Pharmacol Exp Ther"},{"key":"2445_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74230-6","volume":"10","author":"V Schreiner","year":"2020","unstructured":"Schreiner V, Durst M, Arras M, Detampel P, Jirkof P, Huwyler J. Design and in vivo evaluation of a microparticulate depot formulation of buprenorphine for veterinary use. Sci Rep. 2020;10:17295.","journal-title":"Sci Rep"},{"key":"2445_CR45","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/jps.2600691104","volume":"69","author":"F Rubio","year":"1980","unstructured":"Rubio F, Seawall S, Pocelinko R, DeBarbieri B, Benz W, Berger L, et al. Metabolism of carprofen, a nonsteroid anti-inflammatory agent, in rats, dogs, and humans. J Pharm Sci. 1980;69:1245\u201353.","journal-title":"J Pharm Sci"},{"key":"2445_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93336-3","volume":"15","author":"A Glasenapp","year":"2025","unstructured":"Glasenapp A, Bankstahl JP, B\u00e4hre H, Kozlov A, Glage S, Bankstahl M. Favorable pharmacokinetic and tolerability profiles make carprofen an attractive analgesic for subcutaneous injection and oral self-administration in rats. Sci Rep. 2025;15:8932.","journal-title":"Sci Rep"},{"key":"2445_CR47","doi-asserted-by":"publisher","first-page":"228","DOI":"10.30802\/AALAS-JAALAS-24-118","volume":"64","author":"ED Alamaw","year":"2025","unstructured":"Alamaw ED, Tien K, Zhang M, Ge Y, Gorman G, Nagamine CM, et al. Analgesic Efficacy of Oral Carprofen-Treated Gel and Tablets for an Incisional Pain Model in NSG Mice. J Am Assoc Lab Anim Sci. 2025;64:228\u201340.","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"2445_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2024.1430726","volume":"11","author":"A Glasenapp","year":"2024","unstructured":"Glasenapp A, Bankstahl JP, B\u00e4hre H, Glage S, Bankstahl M. Subcutaneous and orally self-administered high-dose carprofen shows favorable pharmacokinetic and tolerability profiles in male and female C57BL\/6J mice. Front Vet Sci. 2024;11:1430726.","journal-title":"Front Vet Sci"},{"key":"2445_CR49","first-page":"387","volume":"53","author":"TS Clark","year":"2014","unstructured":"Clark TS, Clark DD, Hoyt RF. Pharmacokinetic comparison of sustained-release and standard buprenorphine in mice. J Am Assoc Lab Anim Sci JAALAS. 2014;53:387\u201391.","journal-title":"J Am Assoc Lab Anim Sci JAALAS"},{"key":"2445_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40122-019-00143-6","volume":"9","author":"J Gudin","year":"2020","unstructured":"Gudin J, Fudin J. A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain. Pain Ther. 2020;9:41\u201354.","journal-title":"Pain Ther"},{"key":"2445_CR51","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.forsciint.2004.02.035","volume":"143","author":"V Cirimele","year":"2004","unstructured":"Cirimele V, Etienne S, Villain M, Ludes B, Kintz P. Evaluation of the One-Step ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens. Forensic Sci Int. 2004;143:153\u20136.","journal-title":"Forensic Sci Int"},{"key":"2445_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/jat\/30.2.115","volume":"30","author":"EI Miller","year":"2006","unstructured":"Miller EI, Torrance HJ, Oliver JS. Validation of the Immunalysis microplate ELISA for the detection of buprenorphine and its metabolite norbuprenorphine in urine. J Anal Toxicol. 2006;30:115\u20139.","journal-title":"J Anal Toxicol"},{"key":"2445_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jchromb.2013.09.004","volume":"939","author":"KJ Regina","year":"2013","unstructured":"Regina KJ, Kharasch ED. High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;939:23\u201331.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2445_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69075-2","volume":"14","author":"A Munk","year":"2024","unstructured":"Munk A, Philippi V, Buchecker V, Bankstahl M, Glasenapp A, Blutke A, et al. Refining pain management in mice by comparing multimodal analgesia and NSAID monotherapy for neurosurgical procedures. Sci Rep. 2024;14:18691.","journal-title":"Sci Rep"},{"key":"2445_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.applanim.2016.09.009","volume":"185","author":"M Sauer","year":"2016","unstructured":"Sauer M, Fleischmann T, Lipiski M, Arras M, Jirkof P. Buprenorphine via drinking water and combined oral-injection protocols for pain relief in mice. Appl Anim Behav Sci. 2016;185:103\u201312.","journal-title":"Appl Anim Behav Sci"},{"key":"2445_CR56","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0006-8993(91)91394-G","volume":"568","author":"M Kavaliers","year":"1991","unstructured":"Kavaliers M, Colwell DD. Sex differences in opioid and non-opioid mediated predator-induced analgesia in mice. Brain Res. 1991;568:173\u20137.","journal-title":"Brain Res"},{"key":"2445_CR57","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0149-7634(00)00017-8","volume":"24","author":"RB Fillingim","year":"2000","unstructured":"Fillingim RB, Ness TJ. Sex-related hormonal influences on pain and analgesic responses. Neurosci Biobehav Rev. 2000;24:485\u2013501.","journal-title":"Neurosci Biobehav Rev"},{"key":"2445_CR58","doi-asserted-by":"publisher","first-page":"490","DOI":"10.30802\/AALAS-CM-19-000066","volume":"69","author":"JC Smith","year":"2019","unstructured":"Smith JC. A Review of Strain and Sex Differences in Response to Pain and Analgesia in Mice. Comp Med. 2019;69:490\u2013500.","journal-title":"Comp Med"},{"key":"2445_CR59","first-page":"105","volume":"63","author":"KR Jacobsen","year":"2013","unstructured":"Jacobsen KR, Fauerby N, Raida Z, Kalliokoski O, Hau J, Johansen FF, et al. Effects of buprenorphine and meloxicam analgesia on induced cerebral ischemia in C57BL\/6 male mice. Comp Med. 2013;63:105\u201313.","journal-title":"Comp Med"},{"key":"2445_CR60","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41386-019-0585-3","volume":"45","author":"AD Abraham","year":"2020","unstructured":"Abraham AD, Leung EJY, Wong BA, Rivera ZMG, Kruse LC, Clark JJ, et al. Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2020;45:1105\u201314.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"2445_CR61","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/0023677214532454","volume":"48","author":"MJ Molina-Cimadevila","year":"2014","unstructured":"Molina-Cimadevila MJ, Segura S, Merino C, Ruiz-Reig N, Andr\u00e9s B, de Madaria E. Oral self-administration of buprenorphine in the diet for analgesia in mice. Lab Anim. 2014;48:216\u201324.","journal-title":"Lab Anim"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02445-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02445-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02445-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:03:21Z","timestamp":1779253401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02445-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":61,"alternative-id":["2445"],"URL":"https:\/\/doi.org\/10.1038\/s41386-026-02445-8","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}